Tevogen Bio Stock (NASDAQ:TVGN)
Previous Close
$1.33
52W Range
$0.26 - $21.09
50D Avg
$1.14
200D Avg
$2.02
Market Cap
$232.08M
Avg Vol (3M)
$15.65M
Beta
-1.03
Div Yield
-
TVGN Company Profile
Tevogen Bio Holdings Inc. operates as a clinical-stage biotechnology company that develops off-the-shelf precision T cell therapeutics in virology, oncology, and neurology. Its lead investigational precision T cell product, TVGN 489, is designed to address the unmet need of acute-risk COVID-19 patients, as well as a subset of patients suffering from long COVID. The company is based in Warren, New Jersey.